Company will distribute injectable nalmefene for no profit as part of its commitment to help abate the opioid crisis STAMFORD, Conn. – June 21, 2022 – Purdue Pharma L.P. announced today that Nalmefene Hydrochloride injection, 2mg/2mL (1mg/1mL) is now available in the...
Stamford, Conn., March 23, 2022 – Harm Reduction Therapeutics (HRT) will receive up to $11 million of additional financial support from Purdue Pharma L.P. to advance its development of a low-cost, over-the-counter (OTC) naloxone nasal spray in the United States....
Stamford, Conn., March 17, 2022 – Purdue Pharma L.P. is accepting proposals for investigator-initiated research (IIR) to assess opioid overdose reversal in Emergency Department (ED) and Emergency Medical Service (EMS) settings. Because we recognize there is value in...
STAMFORD, Conn. – Feb. 23, 2022 – Purdue Pharma L.P. announced today that FDA has approved its abbreviated new drug application for Nalmefene hydrochloride injection, 2mg/2mL (1mg/1mL).1 Nalmefene is an opioid antagonist indicated for the complete or partial...
STAMFORD, Conn. – Purdue Pharma L.P. today announced its intent to appeal today’s ruling by the United States District Court for the Southern District of New York, which vacated the Bankruptcy Court’s September 2021 order confirming its chapter 11 plan of...
Dedicated to the public good, Knoa Pharma will deliver billions of dollars of value to communities across the country affected by the opioid crisis Knoa Pharma will apply its scientific expertise to develop and distribute opioid addiction treatment and overdose...
Please read carefully the Purdue Pharma L.P. Privacy Policy (the “Privacy Policy”), which is part of the Purdue Pharma L.P. Terms and Conditions, before you access, download, or otherwise use any of our websites, related other parties’ websites, mobile applications, or any electronic service (collectively, the “Service”). This Privacy Policy describes the information collected through Your use of the Service, how we use it, how we share it, how we protect it, and the choices You can make about Your information.
